Although long-term studies on BRAF inhibitors in BRAF-V600E-mutated ameloblastoma are lacking, we see their use to reduce tumor size with consecutive surgical treatment as a reasonable option for therapy. This evidence concerns the gene BRAF and ameloblastoma.